SLU-PP-332 is an ERR (estrogen-related receptor) agonist that has shown remarkable effects on exercise capacity in research.
Research Results
Studies showed 70% increased running capacity and 40% increased endurance with no training.
Mechanism
SLU-PP-332 activates ERRα, ERRβ, and ERRγ, which regulate mitochondrial biogenesis and oxidative metabolism.
Research Benefits
- Dramatically increased endurance
- Enhanced fat oxidation
- Improved metabolic efficiency
- Potential muscle preservation
Dosing
Research dosing protocols still being established. Typically 10-25mg daily.
Research compounds are NOT equivalent to FDA-approved pharmaceuticals.